Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
41 Articles
41 Articles
Globe Device Touted as Advance for Pulsed Field Ablation
(MedPage Today) -- Pulsed field ablation (PFA) technology made some advances with 12-month results for the Globe Pulsed Field System in paroxysmal atrial fibrillation (Afib). In the single-arm PULSAR IDE study of 162 people, the novel PFA system...

Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal AfibDual-energy (RF/PF), focal Sphere-9™ catheter demonstrates efficacy for linear ablation in persistent AFibMedtronic continues legacy of leadership in innovation,…


Kardium reports strong PFA system trial results
Kardium has revealed positive one-year efficacy results on its pulsed field ablation (PFA) device, the Globe PF System.The post Kardium reports strong PFA system trial results appeared first on Medical Device Network.
Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients - PressReach
One-year clinical trial data for the next-generation, investigational, Sphere-360 single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib Dual-energy (RF/PF), focal Sphere-9 catheter demonstrates efficacy for linear ablation in persistent AFib Medtronic continues legacy of leadership in innovation, showcasing arrhythmia management portfolio at Heart Rhythm Society annual meeting GALWAY, Ireland an…
Coverage Details
Bias Distribution
- 90% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage